Pharma & Healthcare
Large-Scale Oligonucleotide Synthesis Services
- Types
- Common Primer Synthesis · Modified Primer Synthesis
- Applications
- Biotech Company · Academic Scientific Research Institution
5 editions23 December 2025
Compare the product scope, applications and research editions relevant to your next decision.
Pharma & Healthcare
5 editions23 December 2025
Pharma & Healthcare
5 editions20 December 2025
Pharma & Healthcare
5 editions21 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
5 editions29 December 2025
Pharma & Healthcare
5 editions30 December 2025
Pharma & Healthcare
5 editions29 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
A biomarker is, according to the US National Institutes of Health, “a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.”
5 editions1 January 2026
Pharma & Healthcare
5 editions30 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
5 editions23 December 2025